John Murphy III
John Murphy III is the CEO of the Association for Accessible Medicines, a trade group representing the generic and biosimilar medicine industry. He has been vocal about the potential negative impact of proposed tariffs on pharmaceutical imports, warning that they could exacerbate drug shortages and hinder the ability of generic drug manufacturers to operate in the United States.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United States | 1 | 5.00 | 0.02% | +0% | 331,002,651 | 72,748 | $21,000,000 | 4,615$ |
| Totals | 1 | 331,002,651 | 72,748 | $21,000,000 | 4,615$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
John Murphy III, CEO of the Association for Accessible Medicines, warned that tariffs could amplify drug shortages concerns.
5